NBIX vs. CVX
NBIX (Neurocrine Biosciences, Inc.) and CVX (Chevron Corporation) are both stocks. NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare), while CVX operates in Oil & Gas Integrated (Energy). Over the past 10 years, NBIX returned 13.16%/yr vs 10.94%/yr for CVX. At a 0.22 correlation, their price movements are largely independent.
Performance
NBIX vs. CVX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NBIX achieves a 12.64% return, which is significantly lower than CVX's 25.18% return. Over the past 10 years, NBIX has outperformed CVX with an annualized return of 13.16%, while CVX has yielded a comparatively lower 10.94% annualized return.
NBIX
- 1D
- -1.81%
- 1M
- -0.97%
- YTD
- 12.64%
- 6M
- 4.55%
- 1Y
- 27.80%
- 3Y*
- 18.64%
- 5Y*
- 10.13%
- 10Y*
- 13.16%
CVX
- 1D
- 0.75%
- 1M
- 1.58%
- YTD
- 25.18%
- 6M
- 27.20%
- 1Y
- 34.55%
- 3Y*
- 10.25%
- 5Y*
- 16.33%
- 10Y*
- 10.94%
NBIX vs. CVX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NBIX Neurocrine Biosciences, Inc. | 12.64% | 3.90% | 3.60% | 10.31% | 40.24% | -11.14% | -10.83% | 50.53% | -7.96% | 100.49% |
CVX Chevron Corporation | 25.18% | 10.10% | 1.29% | -13.63% | 58.46% | 46.24% | -25.95% | 15.27% | -9.75% | 10.59% |
Correlation
The correlation between NBIX and CVX is -0.12, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2001 | 0.22 |
The correlation between NBIX and CVX shifts across timeframes, from -0.12 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.
Fundamentals
NBIX:
$16.52B
CVX:
$371.80B
NBIX:
$6.53
CVX:
$5.75
NBIX:
24.46
CVX:
32.54
NBIX:
0.48
CVX:
3.17
NBIX:
5.27
CVX:
1.93
NBIX:
4.85
CVX:
2.02
NBIX:
$3.10B
CVX:
$185.89B
NBIX:
$3.05B
CVX:
$47.27B
NBIX:
$881.20M
CVX:
$40.44B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NBIX vs. CVX — Risk / Return Rank
NBIX
CVX
NBIX vs. CVX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Neurocrine Biosciences, Inc. (NBIX) and Chevron Corporation (CVX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NBIX | CVX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.68 | ||
| Sortino ratioReturn per unit of downside risk | -0.75 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.27 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 1.34 | 2.48 | -1.15 |
| Martin ratioReturn relative to average drawdown | 2.94 | 6.10 | -3.16 |
Loading charts...
Drawdowns
NBIX vs. CVX - Drawdown Comparison
The maximum NBIX drawdown since its inception was -97.21%, which is greater than CVX's maximum drawdown of -55.77%. Use the drawdown chart below to compare losses from any high point for NBIX and CVX.
Loading charts...
Drawdown Indicators
| NBIX | CVX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.21% | -55.77% | -41.44% |
Max Drawdown (1Y)Largest decline over 1 year | -20.90% | -13.99% | -6.91% |
Max Drawdown (3Y)Largest decline over 3 years | -42.89% | -20.64% | -22.25% |
Max Drawdown (5Y)Largest decline over 5 years | -42.89% | -24.95% | -17.94% |
Max Drawdown (10Y)Largest decline over 10 years | -46.39% | -55.77% | +9.38% |
Current DrawdownCurrent decline from peak | -4.54% | -10.52% | +5.98% |
Average DrawdownAverage peak-to-trough decline | -43.84% | -11.39% | -32.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.49% | 5.68% | +3.81% |
Volatility
NBIX vs. CVX - Volatility Comparison
Neurocrine Biosciences, Inc. (NBIX) has a higher volatility of 9.63% compared to Chevron Corporation (CVX) at 7.62%. This indicates that NBIX's price experiences larger fluctuations and is considered to be riskier than CVX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NBIX | CVX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.63% | 7.62% | +2.01% |
Volatility (6M)Calculated over the trailing 6-month period | 23.91% | 17.86% | +6.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.38% | 22.06% | +9.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.73% | 25.15% | +7.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.13% | 29.16% | +9.97% |
Dividends
NBIX vs. CVX - Dividend Comparison
NBIX has not paid dividends to shareholders, while CVX's dividend yield for the trailing twelve months is around 3.73%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CVX Chevron Corporation | 3.73% | 4.49% | 4.50% | 4.05% | 3.16% | 4.52% | 6.11% | 3.95% | 4.12% | 3.45% | 3.64% | 4.76% |
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NBIX vs. CVX - Financials Comparison
This section allows you to compare key financial metrics between Neurocrine Biosciences, Inc. and Chevron Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NBIX vs. CVX - Profitability Comparison
NBIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.
CVX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Chevron Corporation reported a gross profit of 4.55B and revenue of 47.56B. Therefore, the gross margin over that period was 9.6%.
NBIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.
CVX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Chevron Corporation reported an operating income of 3.24B and revenue of 47.56B, resulting in an operating margin of 6.8%.
NBIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.
CVX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Chevron Corporation reported a net income of 2.21B and revenue of 47.56B, resulting in a net margin of 4.7%.
Frequently Asked Questions
NBIX and CVX have a correlation of -0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NBIX has higher volatility (9.63%) compared to CVX (7.62%). In terms of maximum drawdown, NBIX dropped -97.21% vs CVX's -55.77%.
CVX currently has the higher Sharpe Ratio (1.57 vs 0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NBIX and CVX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer